Hypocalcemia In Neonates

Jagdish Kathwate
MD Pediatrics. Assistant Professor, Government Medical College, Aurangabad, India.
First Created: 01/08/2003  Last Updated: 01/08/2003

Patient Education

What is Hypocalcemia in newborns?

Hypocalcemia is a serum total Ca concentration <8 mg/dL (<2 mmol/L) in term infants or <7 mg/dL (<1.75 mmol/L) in preterm infants. It is also defined as an ionized Ca level <3.0 to 4.4 mg/dL (<0.75 to 1.10 mmol/L), depending on the method (type of electrode) used. Signs are primarily neurologic and include hypotonia, apnea, and tetany.

What causes Hypocalcemia in newborns?

Neonatal hypocalcemia occurs in 2 forms:

  • Early-onset (in the first 2 days of life)
  • Late-onset (>3 days), which is rare

Early-onset hypocalcemia:
Risk factors for early-onset hypocalcemia include prematurity, being small for gestational age, maternal diabetes, and perinatal asphyxia. Mechanisms vary. Normally, the parathyroid hormone helps maintain normal Ca levels when the constant infusion of ionized Ca across the placenta is interrupted at birth. Transient, relative hypoparathyroidism may cause hypocalcemia in preterm and some small-for-gestational-age neonates, who have parathyroid glands that do not yet function adequately, and in infants of mothers with diabetes or hyperparathyroidism, because these women have higher-than-normal ionized Ca levels during pregnancy. Perinatal asphyxia may also increase serum calcitonin, which inhibits Ca release from bone and results in hypocalcemia. In other neonates, the normal phosphaturic renal response to the parathyroid hormone is absent; the elevated phosphate (PO4) level leads to hypocalcemia.

Late-onset hypocalcemia:
The cause of late-onset hypocalcemia is usually ingestion of cow's milk or formula with a too-high PO4 load; elevated serum PO4 leads to hypocalcemia.

What are Symptoms and Signs?

Symptoms and signs rarely occur unless total serum Ca is <7 mg/dL (<1.75 mmol/L) or the ionized Ca is <3.0 mg/dL (<0.75 mmol/L). Signs include hypotonia, tachycardia, tachypnea, apnea, poor feeding, jitteriness, tetany, and seizures. Similar symptoms may occur with hypoglycemia and opioid withdrawal.

Diagnosis is by measurement of serum total or ionized Ca; ionized Ca is the more physiologic measurement because it obviates concerns about protein concentration and pH. Prolongation of the corrected QT interval (QTc) on ECG also suggests hypocalcemia.

What is Treatment?

Early-onset hypocalcemia ordinarily resolves in a few days, and asymptomatic neonates with serum Ca levels >7 mg/dL or ionized Ca>3.5 mg/dL rarely require treatment. Those term infants with levels <7 mg/dL and preterm infants with Ca <6 mg/dL (<1.5 mmol/L) should be treated with 2 mL/kg of 10% Ca gluconate (200 mg/kg) by slow IV infusion over 30 min. The too-rapid infusion can cause bradycardia, so heart rate should be monitored during the infusion. After acute correction of hypocalcemia, Ca gluconate may be mixed in the maintenance IV infusion and given continuously. Starting with 400 mg/kg/day of Ca gluconate, the dose may be increased gradually to 800 mg/kg/day, if needed, to prevent a recurrence. When oral feedings are begun, the formula may be supplemented with the same daily dose of Ca gluconate, if needed, by adding the 10% Ca gluconate solution into the day's formula. Supplementation is usually required for only a few days. Treatment of late-onset hypocalcemia is the addition of calcitriol or additional Ca to infant formula to provide a 4:1 molar ratio of Ca: PO4 until normal Ca levels are maintained.


Hypocalcemia in Neonates Hypocalcemia in Neonates Hypocalcemia in Neonates 08/01/2015
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0